The role of HMGB1 in liver inflammation in obese rats

被引:3
|
作者
Erdal, M. [1 ]
Altunkaynak, B. Z. [2 ]
Kocaman, A. [3 ]
Alkan, I [3 ]
Oztas, E. [1 ]
机构
[1] Gulhane Mil Med Acad, Dept Histol & Embryol, Ankara, Turkey
[2] Istanbul Okan Univ, Med Sch, Dept Histol & Embryol, Istanbul, Turkey
[3] Ondokuz Mayis Univ, Med Sch, Dept Histol & Embryol, Samsun, Turkey
关键词
HMGB1; inflammation; kupffer cell; liver; obesity; rats; stereology; ENDOPLASMIC-RETICULUM STRESS; LIFE-STYLE INTERVENTION; OXIDATIVE STRESS; ADIPOSE-TISSUE; METABOLIC SYNDROME; PATHOGENESIS; EXPRESSION; ANGIOGENESIS; PROGRESSION; MECHANISMS;
D O I
10.1080/10520295.2019.1589573
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Obesity is a chronic disease that is characterized by increased body fat owing to imbalance between consumed and expended energy. Inflammation generally is accompanied by accumulation of excess lipid in adipose tissue and liver. High mobility group box-1 (HMGB1) participates in the pathogenesis of inflammatory diseases. We investigated the relation of the number of HMGB1 positive cells to body mass index (BMI), liver inflammation and the number of Kupffer cells. We divided 18 female Wistar albino rats into two groups: group 1, untreated control fed normal commercial rat diet and group 2, obese rats fed a special diet containing 40% fat. The plasma concentrations of cholesterol, glucose, superoxide dismutase enzyme (SOD) and catalase activities were measured for all animals. The numbers of hepatocytes, Kupffer cells and HMGB1 positive cells were counted using stereological methods. The mean numbers of Kupffer cells and HMGB1 positive cells were higher for group 2 than for group 1. The concentrations of plasma cholesterol and glucose levels also were higher in group 2. Plasma levels of SOD and catalase were significantly lower in group 2 compared to group 1. The number of HMGB1 cells was related directly to BMI and inflammation. The role of HMGB1 was demonstrated for the liver of the obese group. We demonstrated the relations among HMGB1, BMI, obesity and inflammation.
引用
收藏
页码:449 / 458
页数:10
相关论文
共 50 条
  • [41] The Role of HMGB1 on Lipid Packaging in the Intestine
    Gaskell, Harriet
    Ge, Xiaodong
    Lantvit, Daniel
    Guzman, Grace
    Nieto, Natalia
    HEPATOLOGY, 2018, 68 : 226A - 226A
  • [42] Emerging role of HMGB1 in fibrotic diseases
    Li, Liu-Cheng
    Gao, Jian
    Li, Jun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (12) : 2331 - 2339
  • [43] The Role of HMGB1/RAGE in Inflammatory Cardiomyopathy
    Volz, Hans C.
    Kaya, Ziya
    Katus, Hugo A.
    Andrassy, Martin
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (02): : 185 - 194
  • [44] The Role of Hmgb1 in the Development of Diabetic Cardiomyopathy
    Volz, H. Christian
    Seidel, Cathrin
    Laohachewin, Danai
    Lasitschka, Felix
    Bianchi, Marco E.
    Bierhaus, Angelika
    Katus, Hugo A.
    Andrassy, Martin
    CIRCULATION, 2010, 122 (21)
  • [45] The dual role of HMGB1 in pancreatic cancer
    KangRui
    TangDaolin
    胰腺病学杂志(英文), 2018, 1 (01) : 19 - 20-21-22-23-24
  • [46] Preterm Birth: A Modulatory Role for HMGB1?
    Miller, Benjamin
    Shelleh, Amena
    Kirby, John A.
    Robson, Stephen C.
    Tyson-Capper, Alison J.
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 364A - 364A
  • [47] The Role of HMGB1 in the Pathogenesis of Cystic Fibrosis
    Entezari-Zaher, Tahera
    Mantell, Lin
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 : S45 - S45
  • [48] The role of HMGB1 in the pathogenesis of rheumatic disease
    Andersson, Ulf
    Harris, Helena Erlandsson
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (1-2): : 141 - 148
  • [49] Role of Serum HMGB1 in Prostate Cancer
    Solakhan, Mehmet
    Cicek, Hulya
    Benlier, Necla
    Yildirim, Zeliha
    Sever, Ozlem Nuray
    Orhan, Nun
    Yildirim, Mustafa
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (02): : 108 - 112
  • [50] The Role of HMGB1 in Radioresistance of Bladder Cancer
    Shrivastava, Sanhita
    Mansure, Jose Joao
    Almajed, Wael
    Cury, Fabio
    Ferbeyre, Gerardo
    Popovic, Marija
    Seuntjens, Jan
    Kassouf, Wassim
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (03) : 471 - 479